09/02/2026
Georgetown University School of Medicine has appointed Zobair Younossi, MD, MPH, as professor of medicine and founding chair of the new Global Center for Liver Outcomes and Policy Research.
Younossi is a world-renowned hepatologist who established the Global NASH/MASH Council, a network of nearly 300 hepatologists across 63 countries, and the Global Liver Registry, which has enrolled more than 18,000 patients worldwide.
He is focused on a disease often called “hidden” or silent. Metabolic dysfunction-associated steatotic liver disease affects roughly one in three American adults, yet only about 5 percent of at-risk patients are screened in primary care. He wants that to change, so that "patients and primary care physicians are thinking about the liver the same way they think about their eyes, their heart, and their kidneys."
That focus on the whole patient runs through his career. "If the patient at the end of the day is not experiencing wellness, then you've done only half of your job."
We are glad to have you at Georgetown, Dr. Younossi. Read more: https://medicine.georgetown.edu/news-stories/renowned-liver-expert-joins-georgetown-with-eye-to-raising-awareness-of-hidden-disease/
Georgetown’s Zobair Younossi, MD, MPH, has built his career on studying and treating the often-overlooked liver, with far-reaching effects.